{"transactions":[{"id":2825624,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-02T02:01:39.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":139000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest over four years with 25% of the shares of Common Stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 25, 2025."}],"balance_after":139000,"derivative":{"exercise_price":2.35,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":139000},"source":{"system":"sec-edgar","filing":"0001193805-21-000292","document":"e620327_4-mond.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380521000292/e620327_4-mond.xml","form_type":"4"}},{"id":2825623,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Common Stock","published_at":"2021-03-02T02:01:39.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":64361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Of these RSUs, 55,000 RSUs will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 9,361 RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date. The RSUs will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 64,361 RSUs granted on February 25, 2021 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; (ii) 40,000 RSUs granted on February 28, 2020, which vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (ii) 33,174 shares of common stock owned by the reporting person."}],"balance_after":137535,"source":{"system":"sec-edgar","filing":"0001193805-21-000292","document":"e620327_4-mond.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380521000292/e620327_4-mond.xml","form_type":"4"}},{"id":3034167,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Common Stock","published_at":"2020-09-10T12:01:12.000Z","date":"2020-09-08","kind":"purchase","acquired":true,"shares":4000,"price":2.2,"value":8800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 40,000 RSUs granted on February 28, 2020, which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting."}],"balance_after":73174,"source":{"system":"sec-edgar","filing":"0001193805-20-001129","document":"e619922_4-mond.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/e619922_4-mond.xml","form_type":"4"}},{"id":3059923,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Common Stock","published_at":"2020-08-12T12:01:42.000Z","date":"2020-08-10","kind":"purchase","acquired":true,"shares":2000,"price":2.875,"value":5750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 40,000 RSUs granted on February 28, 2020, which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting."}],"balance_after":69174,"source":{"system":"sec-edgar","filing":"0001193805-20-001003","document":"e619854_4-mond.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/e619854_4-mond.xml","form_type":"4"}},{"id":3059922,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Common Stock","published_at":"2020-08-12T12:01:42.000Z","date":"2020-08-10","kind":"purchase","acquired":true,"shares":5000,"price":2.88,"value":14400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 40,000 RSUs granted on February 28, 2020, which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting."}],"balance_after":67174,"source":{"system":"sec-edgar","filing":"0001193805-20-001003","document":"e619854_4-mond.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/e619854_4-mond.xml","form_type":"4"}},{"id":3231177,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-04T00:07:44.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest over four years with 25% of the shares of Common Stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 28, 2024."}],"balance_after":100000,"derivative":{"exercise_price":2.915,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193805-20-000285","document":"e619419_4-mond.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/e619419_4-mond.xml","form_type":"4"}},{"id":3231176,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Common Stock","published_at":"2020-03-04T00:07:44.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"), which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 40,000 RSUs granted on February 28, 2020 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; and (ii) 22,174 shares of common stock owned by the reporting person."}],"balance_after":62174,"source":{"system":"sec-edgar","filing":"0001193805-20-000285","document":"e619419_4-mond.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/e619419_4-mond.xml","form_type":"4"}},{"id":3279387,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO and CMO"}}],"security":"Common Stock","published_at":"2020-02-11T15:16:53.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":4285,"price":3.5,"value":14997.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":22174,"source":{"system":"sec-edgar","filing":"0001193805-20-000133","document":"e619335_4-mond.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/e619335_4-mond.xml","form_type":"4"}},{"id":3516536,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Common Stock","published_at":"2019-05-21T11:12:52.000Z","date":"2019-05-17","kind":"purchase","acquired":true,"shares":4500,"price":4,"value":18000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":17889,"source":{"system":"sec-edgar","filing":"0001193805-19-000522","document":"e618481_4-mond.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/e618481_4-mond.xml","form_type":"4"}},{"id":3686515,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-26T02:31:12.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on February 23, 2020, becoming fully vested on January 23, 2023."}],"balance_after":200000,"derivative":{"exercise_price":3.22,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001193805-19-000091","document":"e618165_4-mond.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380519000091/e618165_4-mond.xml","form_type":"4"}},{"id":4062211,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-14T02:01:55.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on March 9, 2019, becoming fully vested on February 9, 2022."}],"balance_after":150000,"derivative":{"exercise_price":3.71,"expiration_date":"2028-02-09","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193805-18-000190","document":"e617684_4-mond.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380518000190/e617684_4-mond.xml","form_type":"4"}},{"id":4165104,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Common Stock","published_at":"2017-11-13T18:45:05.000Z","date":"2017-11-09","kind":"purchase","acquired":true,"shares":10000,"price":2.15,"value":21500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":13389,"source":{"system":"sec-edgar","filing":"0001193805-17-003449","document":"e617468_4-mond.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517003449/e617468_4-mond.xml","form_type":"4"}},{"id":4288192,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CSO and CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-08T22:01:44.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":242546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on July 6, 2018, becoming fully vested on June 6, 2021."}],"balance_after":242546,"derivative":{"exercise_price":3.66,"expiration_date":"2027-06-06","underlying":"Common Stock","underlying_shares":242546},"source":{"system":"sec-edgar","filing":"0001193805-17-001055","document":"e616262_4-mond.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517001055/e616262_4-mond.xml","form_type":"4"}},{"id":4442117,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":142092,"kind":"person","name":"Mond James","position":1,"cik":"0001554537","reported_name":"Mond James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CSO/CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-17T01:11:31.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on March 14, 2018, becoming fully vested on February 14, 2021."}],"balance_after":22500,"derivative":{"exercise_price":5,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001193805-17-000276","document":"e615798_4-mond.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517000276/e615798_4-mond.xml","form_type":"4"}}]}